Columnist Caroline Gainer is no longer haunted by a weight gain that was crucial in helping her adapt to her COPD and to her ...

There is no need to do any special preparation for this test. However, if you are on oxygen therapy, oxygen values must be constant for 20 minutes before the test. If you are taking medication to make ...

While COPD imposes some limitations, columnist Caroline Gainer has learned that choosing to rest can be a radical act of self ...

Fluticasone (brand name Flovent) is a prescription corticosteroid used to prevent breathing difficulties, chest tightness, wheezing and coughing caused by respiratory disorders such as COPD. It works ...

Formoterol (brand names Perforomist, Foradil) is a bronchodilator in a class of medications called long-acting beta agonists (LABAs). It is used to control wheezing, shortness of breath, coughing and ...

COPD is among the leading causes of death in industrialized countries, and new pharmacological treatments are being developed to help patients with this disease. But a spectrum of non-pharmacological ...

Inflammation is having a moment. It’s the buzzword behind turmeric lattes, elimination diets, and supplement stacks. But for those of us living with chronic obstructive pulmonary disease (COPD), ...

Trelegy Ellipta is a once-daily, single inhaler triple therapy from GSK, in collaboration with Innoviva, approved as a long-term maintenance treatment for certain patients with chronic obstructive ...

November marks COPD Awareness Month, and advocates this year will focus on action, and education about chronic obstructive ...

Each day that I continue to take my antidepressant, I see more and more of the world I used to enjoy before chronic obstructive pulmonary disease (COPD) caused the walls to cave in on me. Though I ...

A Phase 3 clinical trial testing AstraZeneca’s injection therapy benralizumab as a potential treatment for chronic obstructive pulmonary disease (COPD) has failed to meet its main goal of showing the ...

A Phase 3 clinical trial testing AstraZeneca’s injection therapy benralizumab as a potential treatment for chronic obstructive pulmonary disease (COPD) has failed to meet its main goal of showing the ...